Literature DB >> 34774224

Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.

Bo Shen1, Gursimran S Kochhar2, David T Rubin3, Sunanda V Kane4, Udayakumar Navaneethan5, Charles N Bernstein6, Raymond K Cross7, Akira Sugita8, Jason Schairer9, Ravi P Kiran10, Philip Fleshner11, James T McCormick12, André D'Hoore13, Samir A Shah14, Francis A Farraye15, Revital Kariv16, Xiuli Liu17, Joel Rosh18, Shannon Chang19, Ellen Scherl20, David A Schwartz21, Paulo Gustavo Kotze22, David H Bruining4, Jessica Philpott23, Bincy Abraham24, Jonathan Segal25, Rocio Sedano26, Maia Kayal27, Stuart Bentley-Hibbert28, Dino Tarabar29, Sandra El-Hachem2, Priya Sehgal30, Joseph A Picoraro31, Séverine Vermeire32, William J Sandborn33, Mark S Silverberg34, Darrell S Pardi4.   

Abstract

Pouchitis, Crohn's disease of the pouch, cuffitis, polyps, and extraintestinal manifestations of inflammatory bowel disease are common inflammatory disorders of the ileal pouch. Acute pouchitis is treated with oral antibiotics and chronic pouchitis often requires anti-inflammatory therapy, including the use of biologics. Aetiological factors for secondary pouchitis should be evaluated and managed accordingly. Crohn's disease of the pouch is usually treated with biologics and its stricturing and fistulising complications can be treated with endoscopy or surgery. The underlying cause of cuffitis determines treatment strategies. Endoscopic polypectomy is recommended for large, symptomatic inflammatory polyps and polyps in the cuff. The management principles of extraintestinal manifestations of inflammatory bowel disease in patients with pouches are similar to those in patients without pouches.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34774224     DOI: 10.1016/S2468-1253(21)00214-4

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  4 in total

Review 1.  Ileal Pouch-Anal Anastomosis and Pouchitis: The Role of the Microbiota in the Pathogenesis and Therapy.

Authors:  Roberto Gabbiadini; Arianna Dal Buono; Carmen Correale; Antonino Spinelli; Alessandro Repici; Alessandro Armuzzi; Giulia Roda
Journal:  Nutrients       Date:  2022-06-24       Impact factor: 6.706

Review 2.  Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous Polyposis.

Authors:  Guillaume Le Cosquer; Etienne Buscail; Cyrielle Gilletta; Céline Deraison; Jean-Pierre Duffas; Barbara Bournet; Géraud Tuyeras; Nathalie Vergnolle; Louis Buscail
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

Review 3.  Medical management of chronic pouch inflammation.

Authors:  Maia Kayal; Marla C Dubinsky
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-03-03

Review 4.  Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.

Authors:  De-Feng Li; Mei-Feng Yang; Jing Xu; Hao-Ming Xu; Min-Zheng Zhu; Yu-Jie Liang; Yuan Zhang; Cheng-Mei Tian; Yu-Qiang Nie; Rui-Yue Shi; Li-Sheng Wang; Jun Yao
Journal:  Int J Nanomedicine       Date:  2022-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.